cmd events (.xlsx) ================== :download:`Download original .xlsx file from GitHub ` .. contents:: info ---- ==== ============================================================================================================================================== .. ResourceFile\_cmd\_events ==== ============================================================================================================================================== 0 Created by Britta Jewell on 25 March 2021 1 2 This file reads in parameters for the onset of each event annually in the CMD module in the TLO model. Each tab represents one event modelled. ==== ============================================================================================================================================== ever_stroke ----------- ==== ===================================================== ======== ==================================================================================================================================================================================================================================================== .. parameter\_name value Unnamed: 2 ==== ===================================================== ======== ==================================================================================================================================================================================================================================================== 0 baseline\_annual\_probability 0.0038 1 rr\_male 0.9 2 rr\_0\_4 0 3 rr\_5\_9 0 4 rr\_10\_14 0 5 rr\_15\_19 0 6 rr\_20\_24 0.15 7 rr\_25\_29 0.15 8 rr\_30\_34 0.15 9 rr\_35\_39 0.17 10 rr\_40\_44 0.2 11 rr\_45\_49 0.3 12 rr\_50\_54 0.7 13 rr\_55\_59 0.75 14 rr\_60\_64 0.85 15 rr\_65\_69 0.85 16 rr\_70\_74 1 17 rr\_75\_79 1 18 rr\_80\_84 1 19 rr\_85\_89 1 20 rr\_90\_94 1 21 rr\_95\_99 1 22 rr\_100 1 23 rr\_urban 1 24 rr\_wealth\_1 1 25 rr\_wealth\_2 1 26 rr\_wealth\_3 1 27 rr\_wealth\_4 1 28 rr\_wealth\_5 1 29 rr\_bmi\_1 1 30 rr\_bmi\_2 1 31 rr\_bmi\_3 1 32 rr\_bmi\_4 1 33 rr\_bmi\_5 1 34 rr\_low\_exercise 1.45 35 rr\_high\_salt 1.35 36 rr\_high\_sugar 1 37 rr\_tobacco 2.09 38 rr\_alcohol 1.51 39 rr\_marital\_status\_1 1 40 rr\_marital\_status\_2 1 41 rr\_marital\_status\_3 1 42 rr\_in\_education 1 43 rr\_current\_education\_level\_1 1 44 rr\_current\_education\_level\_2 1 45 rr\_current\_education\_level\_3 1 46 rr\_unimproved\_sanitation 1 47 rr\_no\_access\_handwashing 1 48 rr\_no\_clean\_drinking\_water 1 49 rr\_wood\_burning\_stove 1 50 rr\_diabetes 1.8 51 rr\_hypertension 2.64 52 rr\_depression 1.35 53 rr\_chronic\_kidney\_disease 1 54 rr\_chronic\_lower\_back\_pain 1 55 rr\_chronic\_ischemic\_heart\_disease 2.38 56 rr\_cancers 1 57 rr\_hiv 1 58 rr\_ever\_stroke 180 59 rr\_ever\_heart\_attack 1 60 rr\_diabetes\_on\_medication 0.59 UK Prospective Diabetes Study (UKPDS) Group, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), The Lancet 1998 61 rr\_hypertension\_on\_medication 0.66 Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood- pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration, The Lancet 2000 62 rr\_chronic\_kidney\_disease\_on\_medication 1 63 rr\_chronic\_lower\_back\_pain\_on\_medication 1 64 rr\_chronic\_ischemic\_heart\_disease\_on\_medication 0.9 Gelbenegger et al., Aspirin for primary prevention of cardiovascular disease, BMC Medicine 2019 65 rr\_stroke\_on\_medication 1 66 rr\_heart\_attack\_on\_medication 1 ==== ===================================================== ======== ==================================================================================================================================================================================================================================================== ever_heart_attack ----------------- ==== ===================================================== ======= ============================================================================================================================================================================================== .. parameter\_name value Unnamed: 2 ==== ===================================================== ======= ============================================================================================================================================================================================== 0 baseline\_annual\_probability 0.0013 1 rr\_male 1.5 2 rr\_0\_4 0 3 rr\_5\_9 0 4 rr\_10\_14 0 5 rr\_15\_19 0 6 rr\_20\_24 0.05 7 rr\_25\_29 0.05 8 rr\_30\_34 0.05 9 rr\_35\_39 0.05 10 rr\_40\_44 0.1 11 rr\_45\_49 0.1 12 rr\_50\_54 0.25 13 rr\_55\_59 0.25 14 rr\_60\_64 0.5 15 rr\_65\_69 0.6 16 rr\_70\_74 0.9 17 rr\_75\_79 1 18 rr\_80\_84 1 19 rr\_85\_89 1 20 rr\_90\_94 1 21 rr\_95\_99 1 22 rr\_100 1 23 rr\_urban 1 24 rr\_wealth\_1 1 25 rr\_wealth\_2 1 26 rr\_wealth\_3 1 27 rr\_wealth\_4 1 28 rr\_wealth\_5 1 29 rr\_bmi\_1 1 30 rr\_bmi\_2 1 31 rr\_bmi\_3 1 32 rr\_bmi\_4 1 33 rr\_bmi\_5 1 34 rr\_low\_exercise 1.66 35 rr\_high\_salt 1.7 36 rr\_high\_sugar 1 37 rr\_tobacco 1 38 rr\_alcohol 0.6 39 rr\_marital\_status\_1 1 40 rr\_marital\_status\_2 1 41 rr\_marital\_status\_3 1 42 rr\_in\_education 1 43 rr\_current\_education\_level\_1 1 44 rr\_current\_education\_level\_2 1 45 rr\_current\_education\_level\_3 1 46 rr\_unimproved\_sanitation 1 47 rr\_no\_access\_handwashing 1 48 rr\_no\_clean\_drinking\_water 1 49 rr\_wood\_burning\_stove 1 50 rr\_diabetes 3 51 rr\_hypertension 3 52 rr\_depression 1 53 rr\_chronic\_kidney\_disease 1 54 rr\_chronic\_lower\_back\_pain 1 55 rr\_chronic\_ischemic\_heart\_disease 3 56 rr\_cancers 1 57 rr\_hiv 1 58 rr\_ever\_stroke 1 59 rr\_ever\_heart\_attack 1 60 rr\_diabetes\_on\_medication 0.61 UK Prospective Diabetes Study (UKPDS) Group, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), The Lancet 1998 61 rr\_hypertension\_on\_medication 1 62 rr\_chronic\_kidney\_disease\_on\_medication 1 63 rr\_chronic\_lower\_back\_pain\_on\_medication 1 64 rr\_chronic\_ischemic\_heart\_disease\_on\_medication 0.86 Gelbenegger et al., Aspirin for primary prevention of cardiovascular disease, BMC Medicine 2019 65 rr\_stroke\_on\_medication 1 66 rr\_heart\_attack\_on\_medication 1 ==== ===================================================== ======= ==============================================================================================================================================================================================